4,467
Views
61
CrossRef citations to date
0
Altmetric
Report

Discovery and characterization of olokizumab

A humanized antibody targeting interleukin-6 and neutralizing gp130-signaling

, , , , , , , , , , , , & show all
Pages 773-781 | Received 27 Jan 2014, Accepted 20 Mar 2014, Published online: 02 Apr 2014

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.